Bristol Meyers Squibb | search
Click here to view Bristol Meyers Squibb news from 60+ newspapers.
Bookmark or Share- Our company: Industry leadership in BioPharma - Bristol Myers SquibbOur company. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time.
- Bristol Myers Squibb - Bristol Myers Squibb Provides Update on Phase 3 ...Bristol Myers Squibb (NYSE: BMY) today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated Opdivo® (nivolumab) with concurrent chemoradiotherapy (CCRT) followed by Opdivo plus Yervoy® (ipilimumab) versus CCRT followed by ...
- Global Biopharmaceutical Company - Bristol Myers SquibbIf you are a patient in the U.S. struggling to understand your coverage or pay for your medication, we may be able to help. Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Products and medicines - Bristol Myers SquibbBristol Myers Squibb focuses on developing new medicines to address the unmet medical needs of patients with serious diseases. Explore comprehensive information about our products including dosage and safety information.
- Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter and ...NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2021, which reflect strong sales driven by robust commercial execution and significant advancement of the company’s pipeline that further progressed the company’s portfolio renewal.
More
